Eye care company Alcon raises profitability outlook, cuts tariff hit estimate
Eye care company Alcon raises profitability outlook, cuts tariff hit estimate By Simon Ferdinand Eibach
Aug 11 (Reuters) - Swiss-American eye care company Alcon ALCC.S on Monday hiked its profit guidance and lowered its estimate for the full-year tariff impact to $40 million to $90 million, factoring in an anticipated refund of around $60 million from the U.S. government.
The U.S. accounted for 45% of Alcon's net sales in the first half of the year and most of its major production facilities are located there.
Alcon had previously estimated the annual tariff impact at $100 million to $150 million.
It expects its core operating profit margin to grow by 90-190 basis points in 2026, instead of the previously guided 70-170 bps rise.
It also hiked its guidance for core diluted earnings per share for the second time this year, expecting 12-15% growth, versus 10-13% forecast in May.
Q2 net sales rose to $2.78 billion, from $2.58 billion a year ago, narrowly beating LSEG-compiled analysts' consensus.
(Reporting by Simon Ferdinand Eibach in Gdansk, editing by Milla Nissi-Prussak)
((simonferdinand.eibach@thomsonreuters.com))
Recent news on Alcon AG
See all newsBrief: Alcon Acquires Neurotech And Encelto, The Only FDA-Approved Treatment For Mactel Type 2
Brief: Alcon Acquires Neurotech And Encelto, The Only FDA-Approved Treatment For Mactel Type 2
Swiss stocks - Factors to watch on October 19
Brief: FDA Approves Alcon’S BRYTL Eye Drops
Advisory: Alert incorrectly tagged to Omega Interactive Technologies withdrawn